Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients
type: MedicalStudy
description: Optimization of Treatment for Patients With Chronic Hepatitis C Infected With HCV-genotype 2 or 3: 12 vs. 24 Weeks of Treatment Extension for Patients Without Rapid Virological Response
status: TERMINATED
study design: INTERVENTIONAL
phase: PHASE4
start date: 2008-11
end date: 2013-08
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00803309
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: HepNet Study House, German Liverfoundation
study subject: Hepatitis C, Chronic
keywords: PHASE4
keywords: INTERVENTIONAL
keywords: TERMINATED
keywords: Hepatitis C, Chronic

AI Analytics
type: Organization